Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Haferlach

Showing results (81-90 of 596) with videos related to

Pageof 60
Sort By:
British Journal of Haematology|March 16, 2011
Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemiaUlrike Bacher, Torsten Haferlach, Susanne Schnittger, et al.
Blood Advances|June 5, 2023
How I read an article that uses machine learning methodsAziz Nazha, Olivier Elemento, Shannon McWeeney, et al.
Blood|July 15, 2006
Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: A study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expressionFrank Dicker, Susanne Schnittger, Torsten Haferlach, et al.
Current Opinion in Hematology|January 27, 2007
Insight into the molecular pathogenesis of myeloid malignanciesTorsten Haferlach, Ulrike Bacher, Claudia Haferlach, et al.
Blood|January 26, 2006
Implications of NRAS mutations in AML: a study of 2502 patientsUlrike Bacher, Torsten Haferlach, Claudia Schoch, et al.
Cytometry. Part B, Clinical Cytometry|May 30, 2009
Correlation of flow cytometrically determined expression of ZAP-70 using the SBZAP antibody with IgVH mutation status and cytogenetics in 1,229 patients with chronic lymphocytic leukemiaWolfgang Kern, Frank Dicker, Susanne Schnittger, et al.
Annals of Hematology|October 17, 2007
The diagnosis of BCR/ABL-negative chronic myeloproliferative diseases (CMPD): a comprehensive approach based on morphology, cytogenetics, and molecular markersTorsten Haferlach, Ulrike Bacher, Wolfgang Kern, et al.
Acta Haematologica|June 5, 2004
FLT3 length mutations as marker for follow-up studies in acute myeloid leukaemiaSusanne Schnittger, Claudia Schoch, Wolfgang Kern, et al.
Reviews in Clinical and Experimental Hematology|July 20, 2005
Role of gene expression profiling for diagnosing acute leukemiasWolfgang Kern, Alexander Kohlmann, Susanne Schnittger, et al.
Annals of Hematology|February 13, 2013
Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1Verena Patterer, Susanne Schnittger, Wolfgang Kern, et al.
Pageof 60

Showing results (81-90 of 596) with videos related to

Sort By:
Pageof 60
British Journal of Haematology|March 16, 2011
Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemiaUlrike Bacher, Torsten Haferlach, Susanne Schnittger, et al.
Blood Advances|June 5, 2023
How I read an article that uses machine learning methodsAziz Nazha, Olivier Elemento, Shannon McWeeney, et al.
Blood|July 15, 2006
Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: A study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expressionFrank Dicker, Susanne Schnittger, Torsten Haferlach, et al.
Current Opinion in Hematology|January 27, 2007
Insight into the molecular pathogenesis of myeloid malignanciesTorsten Haferlach, Ulrike Bacher, Claudia Haferlach, et al.
Blood|January 26, 2006
Implications of NRAS mutations in AML: a study of 2502 patientsUlrike Bacher, Torsten Haferlach, Claudia Schoch, et al.
Cytometry. Part B, Clinical Cytometry|May 30, 2009
Correlation of flow cytometrically determined expression of ZAP-70 using the SBZAP antibody with IgVH mutation status and cytogenetics in 1,229 patients with chronic lymphocytic leukemiaWolfgang Kern, Frank Dicker, Susanne Schnittger, et al.
Annals of Hematology|October 17, 2007
The diagnosis of BCR/ABL-negative chronic myeloproliferative diseases (CMPD): a comprehensive approach based on morphology, cytogenetics, and molecular markersTorsten Haferlach, Ulrike Bacher, Wolfgang Kern, et al.
Acta Haematologica|June 5, 2004
FLT3 length mutations as marker for follow-up studies in acute myeloid leukaemiaSusanne Schnittger, Claudia Schoch, Wolfgang Kern, et al.
Reviews in Clinical and Experimental Hematology|July 20, 2005
Role of gene expression profiling for diagnosing acute leukemiasWolfgang Kern, Alexander Kohlmann, Susanne Schnittger, et al.
Annals of Hematology|February 13, 2013
Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1Verena Patterer, Susanne Schnittger, Wolfgang Kern, et al.
Pageof 60